It mediated ccRCC carcinogenesis by affecting cancer cells’ malignant invasiveness via the TIMP-1/MMP2/MMP9 and MDM2/p53/Bcl2/Bax pathways. This evidence concerns the gene TP53 and nonpapillary renal cell carcinoma.